Teva Pharmaceutical Industries Ltd. reported Tuesday that on a non-GAAP (generally accepted accounting principles) basis, it earned $1.1 billion net…
Glatiramer acetate (Copaxone or Copolymer 1, Teva Pharmaceuticals) is an immunomodulator drug for treating multiple sclerosis. It is a combination of four amino acids found in myelin basic protein, and may work as a decoy for the immune system. The clinical definition of multiple sclerosis requires two or more episodes of symptoms and signs. Glatiramer acetate is approved for treatment after single episodes, and also for relapsing-remitting multiple sclerosis. It is administered by subcutaneous injection.






















